Gadobenate dimeglumine

DRUG14 trials

Sponsors

Iqvia Rds France, Bracco Diagnostics, Inc, University of Utah, Guerbet, University of Southern California

Conditions

Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Choroid Plexus NeoplasmAdult Diffuse AstrocytomaAdult Ependymoblastoma

Phase 2

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients

CompletedNCT01710254

University of UtahAtrial Fibrillation, Coronary Artery Disease

Start: 2013-01-31End: 2016-10-31Updated: 2017-12-13

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

CompletedNCT02633501

GuerbetBlood Brain Barrier Defect, CNS Lesion

Start: 2016-06-30End: 2018-01-31Updated: 2021-10-25

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

CompletedNCT03703492

University of Wisconsin, MadisonBreast Cancer, Ductal Carcinoma in Situ - Category

Start: 2019-01-03End: 2024-01-02Updated: 2025-02-12

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

WithdrawnNCT04910425

Northwestern UniversityProstate Carcinoma

Start: 2023-06-17End: 2028-07-31Updated: 2025-10-21

Phase 3

Safety and Efficacy of MultiHance in Pediatric Patients

TerminatedNCT00323310

Bracco Diagnostics, IncCentral Nervous System Diseases

Start: 2006-04-30End: 2008-09-30Updated: 2010-10-22

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

CompletedNCT01260636

Bracco Diagnostics, IncCarotid, Aortic, Renal or Peripheral Artery Disease

Start: 2009-09-30End: 2011-12-31Updated: 2012-01-05

Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

Not yet recruitingNCT06406517

University of California, San DiegoCongenital Heart Disease

Start: 2024-05-31End: 2025-06-30Target: 160Updated: 2024-05-09

Phase 4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

RecruitingNCT04373564

GuerbetCognitive Function, Contrast Media, Motor Function

Start: 2021-03-24End: 2028-12-31Target: 2076Updated: 2026-01-22

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

TerminatedNCT04973007

University of Colorado, DenverColorectal Cancer, Liver Metastases, Oligometastatic Disease

Start: 2021-06-22End: 2025-05-08Updated: 2025-07-02

Prospective evaluation of potential effects of repeated gadolinium-based contrast agent (GBCA) administrations of the same GBCA on motor and cognitive functions in neurologically normal adults in comparison to a non-GBCA exposed control group—ODYSSEY

Not yet recruitingCTIS2024-515462-14-00

Iqvia Rds FranceLong term potential effect of repeated exposure to either a linear or a macrocyclic gadolinium-based contrast agent (GBCA) on change from baseline to Year 5 in motor and cognitive function among neurologically normal adults in comparison to a matched non-GBCA–exposed control group effects regarding.

Target: 717Updated: 2025-01-10

Unknown Phase

Retrospective Study of MRI in Pediatric Patients

CompletedNCT02291822

Bracco Diagnostics, IncCentral Nervous System Disease, Central Nervous System Neoplasms

Start: 2014-11-30End: 2015-12-31Updated: 2016-07-19

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

TerminatedNCT02967380

University of Southern CaliforniaAdult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic (Malignant) Meningioma +22

Start: 2011-12-14End: 2015-10-14Updated: 2017-03-27

QSM and Regional DCE MRI Permeability Using GOCART Technique

WithdrawnNCT03091803

University of Southern CaliforniaIntracranial Neoplasm

Start: 2017-04-04End: 2021-04-04Updated: 2021-04-05

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

CompletedNCT04132843

M.D. Anderson Cancer CenterBrain Neoplasm, Lymphoma, Metastatic Malignant Neoplasm in the Brain +1

Start: 2020-01-10End: 2022-09-01Updated: 2022-11-21